Signaling Pathways - prostaglandin FP receptor - Myosin light chain kinases (MLCKs) - Topoisomerases
清除全部
- B4575 AL 8810Target: prostaglandin FP receptorSummary: 前列腺素F2α(FP)受体拮抗剂
- B4745 (S)-10-Hydroxycamptothecin中文名: 羟喜树碱Target: TopoisomerasesSummary: 拓扑异构酶I抑制剂
- B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 蛋白激酶抑制剂
- B7382 Ellipticine中文名: 玫瑰树碱,椭圆玫瑰树碱Target: TopoisomerasesSummary: DNA拓扑异构酶II抑制剂
- B3523 Fasudil中文名: 法舒地尔Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 钙拮抗剂
- B2295 Pirarubicin1 Citation中文名: 吡柔比星Target: TopoisomerasesSummary: 拓扑异构酶II抑制剂,蒽环类抗生素
- B1801 Norfloxacin中文名: 诺氟沙星Target: TopoisomerasesSummary: 拓扑异构酶抑制剂
- B2293 Irinotecan HCl Trihydrate中文名: 盐酸依立替康三水合物Target: TopoisomerasesSummary: 拓扑异构酶I抑制剂
- B2290 Beta-Lapachone中文名: β-拉帕醌Target: TopoisomerasesSummary: 选择性DNA拓扑异构酶I抑制剂
- A8400 Clinafloxacin CI96 AM1091中文名: 克林沙星Target: TopoisomerasesSummary: 拓扑异构酶抑制剂